Invesco Ltd. Sells 33,931 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Invesco Ltd. trimmed its position in Simulations Plus, Inc. (NASDAQ:SLP) by 7.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 411,002 shares of the technology company’s stock after selling 33,931 shares during the quarter. Invesco Ltd. owned about 2.05% of Simulations Plus worth $11,463,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Jones Financial Companies Lllp raised its position in shares of Simulations Plus by 53.6% during the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company’s stock valued at $34,000 after buying an additional 427 shares in the last quarter. AlphaQuest LLC increased its stake in Simulations Plus by 502.9% during the fourth quarter. AlphaQuest LLC now owns 2,689 shares of the technology company’s stock worth $75,000 after acquiring an additional 2,243 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new stake in Simulations Plus during the fourth quarter valued at approximately $86,000. Quantbot Technologies LP lifted its stake in shares of Simulations Plus by 191.6% in the 4th quarter. Quantbot Technologies LP now owns 5,371 shares of the technology company’s stock valued at $150,000 after purchasing an additional 3,529 shares during the last quarter. Finally, US Bancorp DE boosted its holdings in shares of Simulations Plus by 14.3% in the 4th quarter. US Bancorp DE now owns 5,687 shares of the technology company’s stock worth $159,000 after purchasing an additional 713 shares during the period. 78.08% of the stock is currently owned by hedge funds and other institutional investors.

Simulations Plus Price Performance

Shares of SLP stock opened at $35.38 on Wednesday. The company has a market capitalization of $711.53 million, a P/E ratio of 88.45 and a beta of 1.13. The company’s 50-day simple moving average is $28.48 and its two-hundred day simple moving average is $30.15. Simulations Plus, Inc. has a one year low of $23.01 and a one year high of $51.22.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.25 by $0.06. The company had revenue of $22.43 million for the quarter, compared to analysts’ expectations of $21.93 million. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. Simulations Plus’s revenue was up 22.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.20 earnings per share. On average, research analysts expect that Simulations Plus, Inc. will post 1.09 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts recently issued reports on the company. William Blair restated an “outperform” rating on shares of Simulations Plus in a research report on Wednesday, January 8th. StockNews.com lowered shares of Simulations Plus from a “hold” rating to a “sell” rating in a report on Monday, April 14th. Finally, KeyCorp upped their price target on shares of Simulations Plus from $32.00 to $40.00 and gave the company an “overweight” rating in a report on Wednesday, April 16th. One analyst has rated the stock with a sell rating, one has given a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $50.00.

Insider Activity

In other news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $33.91, for a total transaction of $678,200.00. Following the transaction, the director now directly owns 3,402,584 shares in the company, valued at approximately $115,381,623.44. This trade represents a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 19.40% of the company’s stock.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.